Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: The women and infants transmission study

Journal of Infectious Diseases

Volumn 189, Issue 5, 2004, Pages 847-851

  LaMonte, Ashley C ^a,e   Paul, Mary E ^b   Read, Jennifer S ^c   Frederick, Margaret M ^d   Erdman, Dean D ^a   Han, Linda L ^a   Anderson, Larry J ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d Clinical Trials and Surveys   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ANEMIA; ARTICLE; CHILD; ERYTHEMA INFECTIOSUM; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; PREVALENCE; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANEMIA; COHORT STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; FOLLOW-UP STUDIES; HIV SERONEGATIVITY; HUMANS; INFANT, NEWBORN; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RISK FACTORS; TIME FACTORS;

EID: 1542327559     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/381899     Document Type: Article

References (17)

1. Woolf AD, Campion GV, Chishick A, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 1989; 149:1153-6.
2. Anderson LJ. Human parvoviruses. J Infect Dis 1990; 161:603-8.
3. Frickhofen N, Abkowitz JL, Safford M, et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1: a treatable cause of anemia in AIDS. Ann Intern Med 1990; 113: 926-33.
4. Griffin TC, Squires JE, Timmons CF, Buchanan GR. Chronic human parvovirus B19-induced erythroid hypoplasia as the initial manifestation of human immunodeficiency virus infection. J Pediatr 1991; 118:899-901.
5. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red-cell aplasia often years' duration due to persistent parvovirusB19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989; 321:519-23.
6. Kurtzman GJ, Cohen BJ, Field AM, Osease R, Blaese TM, Young NS. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989; 84:1114-23.
7. Flunker G, Peters A, Wiersbitzky S, Modrow S, Siedel W. Persistent parvovirus B19 infections in immunocompromised children. Med Microbiol Immunol 1998; 186:189-94.
8. Chernak E, Dubin G, Henry D, et al. Infection due to parvovirus B19 in patients infected with HIV. Clin Infect Dis 1995; 20:170-3.
9. Abkowitz JL, Brown KE, Wood RW, Kovach NL, Green SW, Young NS. Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis 1997; 176: 269-73.
10. Sheon AR, Fox HE, Rich KC, et al. The Women and Infants Transmission Study of maternal-infant HIV transmission: study design, methods, and baseline data. J Womens Health 1996; 5:69-78.
11. Centers for Disease Control and Prevention. 1994 Revised classification system for HIV infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994; 43:1-10.
12. Durigon EL, Erdman DD, Gary GW, Pallansch MA, Török TJ, Anderson LJ. Multiple primer pairs for polymerase chain reaction amplification of human parvovirus B19 DNA. J Virol Methods 1993; 44: 155-65.
13. Erdman DD, Usher MJ, Tsou C, et al. Human parvovirus B19 specific IgG, IgA and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J Med Virol 1991; 35:110-5.
14. Anderson LJ, Tsou C, Parker RA, et al. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol 1986; 24:522-6.
15. Kerr JR, Curran MD, Moore JE, Murphy PG. Parvovirus B19 infection: persistence and genetic variation. Scand J Infect Dis 1995; 27:551-7.
16. Jones LP, Erdman DD, Anderson LJ. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection. J Infect Dis 1999; 180:500-4.
17. Oski FA, Brugnara C, Nathan DG. A diagnostic approach to the anemic patient. In: Nathan G, Orkin SH, eds. Nathan and Oski's hematology of infancy and childhood. 5th ed. Philadelphia: WB Saunders, 1998:376.